| 1 |
Perner Anders, Cecconi Maurizio, Cronhjort Maria, et al. Expert statement for the management of hypovolemia in sepsis[J]. Intensive Care Med, 2018, 44(6): 791-798.
|
| 2 |
Prescott HC, Angus DC. Postsepsis Morbidity[J]. JAMA, 2018, 319(1): 91.
|
| 3 |
Reinhart K, Daniels R, Kissoon N, et al. Recognizing Sepsis as a Global Health Priority-A WHO Resolution[J]. N Engl J Med, 2017, 377(5): 414-417.
|
| 4 |
唐轶珣，祝益民. 脓毒症/脓毒性休克的循环管理《拯救脓毒症运动：脓毒症与脓毒性休克治疗国际指南(2016版)》解读[J]. 实用休克杂志(中英文), 2017, 1(2): 120-122.
|
| 5 |
Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine[J]. Chest, 1992, 101(6): 1644-1655.
|
| 6 |
Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference[J]. Intensive Care Med, 2003, 29(4): 530-538.
|
| 7 |
Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3)[J]. JAMA, 2016, 315(8): 801-810.
|
| 8 |
任成山，刘绪钊，郭中杰，等. 全身炎症反应综合征1292例临床分析[J]. 中华内科杂志，1999(1): 39-42.
|
| 9 |
Kaukonen KM, Bailey M, Pilcher D, et al. Systemic inflammatory response syndrome criteria in defining severe sepsis[J]. N Engl J Med, 2015, 372(17): 1629-1638.
|
| 10 |
张 宁，周明明，蒋正英，等. 肺癌合并脓毒症mHLA-DR、CD39＋ Treg及IL-10表达与预后相关性分析[J/CD]. 中华肺部疾病杂志(电子版), 2023, 16(2): 169-174.
|
| 11 |
曹 钰，柴艳芬，邓 颖，等. 中国脓毒症/脓毒性休克急诊治疗指南(2018)[J]. 临床急诊杂志，2018, 19(9): 567-588.
|
| 12 |
Vincent JL, Marshall JC, Namendys-Silva SA, et al. Assessment of the worldwide burden of critical illness: the intensive care over nations (ICON) audit[J]. Lancet Respir Med, 2014, 2(5): 380-386.
|
| 13 |
Moreno R, Rhodes A, Piquilloud L, et al. The sequential organ failure assessment (SOFA) score: has the time come for an update[J]. Crit Care, 2023, 27(1): 15.
|
| 14 |
Xia Y, Zou L, Li D, et al. The ability of an improved qSOFA score to predict acute sepsis severity and prognosis among adult patients[J]. Medicine, 2020, 99(5): e18942.
|
| 15 |
Harris S. Sepsis-3: Syndromes and empiricism in the age of big data[J]. Am J Respir Crit Care Med, 2017, 195(7): 847-849.
|
| 16 |
王俊峰，赵 亮，王俊杰，等. 脓毒血症肝损伤患者血清TBA、ALP水平与凝血功能特征观察[J]. 肝脏，2022, 27(5): 593-595.
|
| 17 |
Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine[J]. Intensive Care Med, 1996, 22(7): 707-710.
|
| 18 |
Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign：international guidelines for management of sepsis and septic shock 2021[J]. Intensive Care Med, 2021, 47(11): 1181-1247.
|
| 19 |
Vincent JL, Bakker J. Blood lactate levels in sepsis: in 8 questions[J]. Curr Opin Crit Care, 2021, 27(3): 298-302.
|
| 20 |
Brodie D, Slutsky AS, Combes A. Extracorporeal Life Support for Adults With Respiratory Failure and Related Indications: A Review[J]. JAMA, 2019, 322(6): 557-568.
|
| 21 |
赵云峰，徐志华，巫梦娜，等. 血清miR-133a在脓毒症并发ARDS中表达及预后的关系[J/CD]. 中华肺部疾病杂志(电子版), 2022, 15(1): 38-41.
|
| 22 |
Schenck EJ, Hoffman KL, Cusick M, et al. Critical carE database for advanced research (CEDAR): An automated method to support intensive care units with electronic health record data[J]. J Biomed Inform, 2021, 118: 103789.
|
| 23 |
谢 云，周志刚，田 锐，等. 重组人促血小板生成素改善脓毒症患者心肌损伤的临床研究[J/CD]. 中华肺部疾病杂志(电子版), 2020, 13(2): 213-217.
|
| 24 |
Reintam BA, Padar M, Mandul M, et al. Development of the Gastrointestinal Dysfunction Score (GIDS) for critically ill patients-A prospective multicenter observational study (iSOFA study)[J]. Clin Nutr, 2021, 40(8): 4932-4940.
|
| 25 |
Brinton DL, Ford DW, Martin RH, et al. Missing data methods for intensive care unit SOFA scores in electronic health records studies: results from a Monte Carlo simulation[J]. J Comp Eff Res, 2022, 11(1): 47-56.
|
| 26 |
任成山，林 辉，杨仕明. 循证医学应用中临床经验的重要性[J/CD]. 中华肺部疾病杂志(电子版), 2020, 13(3): 293-296.
|
| 27 |
Heming N, Azabou E, Cazaumayou X, et al. Sepsis in the critically ill patient: current and emerging management strategies[J]. Expert Rev Anti Infect Ther, 2021, 19(5): 635-647.
|
| 28 |
Antcliffe DB, Burnham KL, Al-Beidh F, et al. Transcriptomic signatures in sepsis and a differential response to steroids. From the VANISH randomized trial[J]. Am J Respir Crit Care Med, 2019, 199(8): 980-986.
|
| 29 |
Wong HR, Lindsell CJ, Pettila V, et al. A multibiomarker-based outcome risk stratification model for adult septic shock*[J]. Crit Care Med, 2014, 42(4): 781-789.
|
| 30 |
John PD, Sarah MS, Patricia K, et al. Impact of reducing time-to-antibiotics on sepsis mortality, antibiotic use, and adverse events. Ann Am Thorac Soc, 2023, doi: 10.1513/AnnalsATS.202306-505OC
|